News & Research
Hyperbaric Oxygen Therapy has been used for the better part of two centuries. Search our arhives below for past HBOT news and research or scroll down for the latest.
The Latest HBOT News & Research
Clinical Trial – Effect of Intravenous Dexmedetomidine on Patient Discomfort in Laparoscopic Cholecystectomy Under Spinal Anesthesia.
Laparoscopic cholecystectomy (LC) has been routinely performed under general anesthesia
despite the several disadvantages of general anesthesia compared to regional anesthesia.
There are multiple reports that have been published regarding the feasibility of spinal
anesthesia for LC associated with many problems such as referred shoulder pain secondary to
intra-abdominal pneumoperitoneum; patient anxiety, pain, and discomfort; and inadequate
sedation.The aim of our study is to prospectively observe the feasibility of using
intravenous dexmedetomidine to abolish patient discomfort and shoulder pain, thus making the
patient more comfortable without causing excessive sedation and respiratory depression.
Clinical Trial – The Efficacy of Pain Control After Total Hip Replacement Between Ultrasound Guided Supra-inguinal Fascia Iliaca Block and Intrathecal Morphine
Total hip replacement is one of major orthopedic surgery which result in severe postoperative
pain especially at first 24 hours. Ultrasound guided regional anesthesia has become a part of
multimodal analgesia.Ultrasound guided supra-inguinal fascia iliaca block is a new technique
which can consistently cover femoral and lateral femoral cutaneous nerve. And with large
volume (40ml), it may cover obturator nerve. This technique already proved to be useful for
acute pain control in hip fracture or postoperative control in dynamic hip screw or nail
insertion operation. However, it has not been compared with intrathecal morphine for total
hip replacement yet.
Fargo VA to offer hyperbaric oxygen therapy for vets as part of pilot program
Other four facilities in the program have a 100% success rate in helping brain wounds for veteransHEALING UNDER PRESSURE: HYPERBARIC OXYGEN THERAPY (HBOT) CLINICAL DEMONSTRATION EXPANDS TO TWO MORE SITESVeterans in South-Central Texas and Central...
Clinical Trial – Intrathecal Bupivacaine-fentanyl and Bupivacaine-dexmedetomidine for Elective Low Segment Caesarean Section
the primary objective of the study is to compare the onset and recovery times of sensory and
motor blockade of the two study drugs intrathecally with low dose bupivacaine The secondary
objectives of the study are to observe hemodynamics, side effects profile, and duration of
postoperative analgesia
Clinical Trial – Acute Hyperbaric Oxygen (HBO) Treatment Increases Hepatic Insulin Sensitivity and Muscle Reactive Oxygen Species in Type 2 Diabetes
Diabetes mellitus type 2 (T2D) is characterized by insulin resistance of liver and skeletal
muscle, which is at least partly due to impaired muscle mitochondrial function. Long-term HBO
therapy, as applied for treating the diabetic foot syndrome, has been shown to improve blood
glucose concentrations. To study the underlying mechanisms, we want to examin the short-term
effect of HBO treatment on insulin sensitivity and mitochondrial oxidative capacity and
production of reactive oxygen species (ROS) in a randomized, double blinded,
placebo-controlled cross-over trial.
What is Crohn’s Disesase?
Crohn’s disease is an inflammatory bowel disease (IBD). It causes inflammation of your digestive tract, which can lead to abdominal pain, severe diarrhea, fatigue, weight loss and malnutrition. Inflammation caused by Crohn’s disease can involve different areas of the digestive tract in different people.
The inflammation caused by Crohn’s disease often spreads deep into the layers of affected bowel tissue. Crohn’s disease can be both painful and debilitating, and sometimes may lead to life-threatening complications.
While there’s no known cure for Crohn’s disease, therapies can greatly reduce its signs and symptoms and even bring about long-term remission. With treatment, many people with Crohn’s disease are able to function well.
What is Ulcerative Colitis?
Ulcerative colitis (UL-sur-uh-tiv koe-LIE-tis) is an inflammatory bowel disease (IBD) that causes long-lasting inflammation and ulcers (sores) in your digestive tract. Ulcerative colitis affects the innermost lining of your large intestine (colon) and rectum. Symptoms usually develop over time, rather than suddenly.
Ulcerative colitis can be debilitating and can sometimes lead to life-threatening complications. While it has no known cure, treatment can greatly reduce signs and symptoms of the disease and even bring about long-term remission.
Understanding Ulcerative Colitis vs Crohn’s Disease
Ulcerative colitis vs. Crohn’s disease
Both ulcerative colitis and Crohn’s disease are inflammatory bowel diseases (IBDs), but there are some key differences.
Ulcerative colitis:
Limited to the large intestine (colon and rectum)
Clinical Trial – Height Versus Height and Weight Based Spinal Bupivacaine on Maternal Haemodynamics for Elective Cesarean in Short Stature Patients
Doses of intrathecal bupivacaine based on patients either height or height and weight has
shown to lower the risk of maternal hypotension with similar quality of anesthesia compared
to conventional doses.
In clinical practice there is a tendency of reducing the dose of bupivacaine as either low
fixed dose or using the doses based on either height and weight or height (0.06mg/cm) alone
in parturient with short stature. However, there is lack of evidence regarding the
appropriate dose required in this group of patients. Therefore, our aim is to compare the
height versus height and weight based intrathecal bupivacaine dose for elective caesarean on
maternal haemodynamics in short stature patients.